AAP
Aristotle Atlantic Partners Portfolio holdings
AUM
$3.29B
This Quarter Return
+8.54%
1 Year Return
+24.5%
3 Year Return
+129.49%
5 Year Return
+188.87%
10 Year Return
–
AUM
$3.09B
AUM Growth
+$3.09B
(+0.74%)
Cap. Flow
+$176M
Cap. Flow
% of AUM
5.71%
Top 10 Holdings %
Top 10 Hldgs %
49.94%
Holding
96
New
4
Increased
10
Reduced
59
Closed
2
Top Buys
| 1 |
NVIDIA
NVDA
|
$294M |
| 2 |
Apple
AAPL
|
$26.5M |
| 3 |
Boston Scientific
BSX
|
$18M |
| 4 |
Microchip Technology
MCHP
|
$14.2M |
| 5 |
Analog Devices
ADI
|
$13.8M |
Top Sells
| 1 |
ON Semiconductor
ON
|
$19.2M |
| 2 |
Abbott
ABT
|
$18.6M |
| 3 |
Accenture
ACN
|
$16.9M |
| 4 |
Teleflex
TFX
|
$15.8M |
| 5 |
Microsoft
MSFT
|
$15.5M |
Sector Composition
| 1 | Technology | 40.82% |
| 2 | Healthcare | 12.91% |
| 3 | Communication Services | 10.84% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Financials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Adobe
ADBE
$151B
| $30.3M | 0.98% |
54,500
-419
| -0.8% | -$233K |
|
27
Exxon Mobil
XOM
$487B
| $29M | 0.94% |
251,482
-4,000
| -2% | -$460K |
|
28
O'Reilly Automotive
ORLY
$88B
| $26.3M | 0.85% |
24,858
-3,019
| -11% | -$3.19M |
|
29
UnitedHealth
UNH
$281B
| $26M | 0.84% |
51,024
-308
| -0.6% | -$157K |
|
30
Intercontinental Exchange
ICE
$101B
| $25.8M | 0.84% |
188,720
-25,513
| -12% | -$3.49M |
|
31
Applied Materials
AMAT
$128B
| $25.7M | 0.83% |
109,043
-38,338
| -26% | -$9.05M |
|
32
Vertex Pharmaceuticals
VRTX
$100B
| $24.6M | 0.8% |
52,586
-6,136
| -10% | -$2.88M |
|
33
Ameriprise Financial
AMP
$48.5B
| $24.6M | 0.8% |
57,598
-7,126
| -11% | -$3.04M |
|
34
Cigna
CI
$80.3B
| $23.5M | 0.76% |
70,957
-13,600
| -16% | -$4.5M |
|
35
Chubb
CB
$110B
| $23.4M | 0.76% |
91,861
-20,769
| -18% | -$5.3M |
|
36
Marriott International Class A Common Stock
MAR
$72.7B
| $23.2M | 0.75% |
95,933
-13,887
| -13% | -$3.36M |
|
37
DexCom
DXCM
$29.5B
| $22.6M | 0.73% |
199,254
-1,208
| -0.6% | -$137K |
|
38
Avery Dennison
AVY
$13.4B
| $22.6M | 0.73% |
103,266
-12,169
| -11% | -$2.66M |
|
39
Guardant Health
GH
$8.41B
| $21.6M | 0.7% |
749,197
-57,698
| -7% | -$1.67M |
|
40
NextEra Energy, Inc.
NEE
$148B
| $21.4M | 0.69% |
301,842
-44,406
| -13% | -$3.14M |
|
41
Union Pacific
UNP
$133B
| $21.3M | 0.69% |
94,350
| – | – |
|
42
Idexx Laboratories
IDXX
$51.8B
| $20.9M | 0.68% |
42,906
-160
| -0.4% | -$78K |
|
43
Eli Lilly
LLY
$657B
| $20.6M | 0.67% |
22,777
+14,503
| +175% | +$13.1M |
|
44
Roper Technologies
ROP
$56.6B
| $18.8M | 0.61% |
33,380
-14,860
| -31% | -$8.38M |
|
45
Becton Dickinson
BDX
$55.3B
| $18.8M | 0.61% |
80,505
-11,696
| -13% | -$2.73M |
|
46
Chart Industries
GTLS
$8.96B
| $18.4M | 0.6% |
127,493
-16,963
| -12% | -$2.45M |
|
47
Murphy USA
MUSA
$7.26B
| $18.3M | 0.59% |
38,938
-1,975
| -5% | -$927K |
|
|
48
Boston Scientific
BSX
$156B
| $18M | 0.58% |
+233,209
| New | +$18M |
|
49
Zoetis
ZTS
$69.3B
| $17.1M | 0.55% |
98,782
-13,446
| -12% | -$2.33M |
|
50
General Motors
GM
$55.8B
| $16.1M | 0.52% |
347,586
-43,450
| -11% | -$2.02M |
|